US.WST · West Pharmaceutical Services

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.4588969086259316,
        "turnoverUsdM": 495.122535086,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.WST",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 305.4958,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 6.9,
      "take_profit_price": 353.0043,
      "target_multiplier": 1.9,
      "technical_strength": 1.73,
      "take_profit_percent": 7.6
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.917793817251863,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 56.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 42.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 14
  },
  "market": {
    "ma20": 356.236,
    "ma50": 334.7358,
    "close": 328.2,
    "prevClose": 355.48,
    "avgVolume20": 816770,
    "volumeRatio": 1.85,
    "changePercent": -7.67
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 14,
    "details": {
      "ret_5d": -0.08385434579763129,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 14,
      "vcp_bonus": 0,
      "vol_ratio": 1.8350454017430864,
      "ret_points": 0,
      "vol_points": 6,
      "range_ratio": 2.7459574884636413,
      "volat_points": 4,
      "day_range_pct": 0.0725777247843471,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 56.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.2,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 64,
        "contribution": 3.2
      },
      {
        "raw": 7.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 38,
        "contribution": 7.6
      },
      {
        "raw": 5.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 36,
        "contribution": 5.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.5,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 65,
        "contribution": 6.5
      },
      {
        "raw": 13.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 45,
        "contribution": 13.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 42.2,
    "details": [
      "基本面分析總分: 3.2/5分",
      "資金流分析總分: 7.6/20分",
      "市場環境分析總分: 5.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.5/10分",
      "技術信號分析總分: 13.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.2,
      "資金流": 7.6,
      "市場環境": 5.4,
      "情緒分析": 4,
      "技術信號": 13.5,
      "風險管理": 6.5
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.6,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 495.122535086,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 2.4,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.WST",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.7
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 711.71300025,
                "ma50": 718.2872022,
                "name": "QQQ",
                "close": 684.22998,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.1530053500001,
                "ma50": 745.0680014400001,
                "name": "SPY",
                "close": 738.92999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.4588969086259316,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141022425,
                "url": "https://finnhub.io/api/news?id=d1f78928e7480655f340713dfd950836c30c45378585800c56edff87a7b3ebc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (NYSE:WST) has entered new long-term exclusive and non-exclusive distributorship agreements with Daikyo Seiko. West Pharmaceutical will distribute Daikyo products outside Japan, while Daikyo will distribute more West products within Japan. The agreements are structured to run over the next decade, reinforcing the companies' cross-border partnership in drug packaging technologies. West Pharmaceutical Services comes into this new distribution arrangement with...",
                "category": "company",
                "datetime": 1785042740,
                "headline": "West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan"
              },
              {
                "id": 141005494,
                "url": "https://finnhub.io/api/news?id=7dcccb74b106c019d246e857f0bdac3ee97e6369aa115bcd9f80be7816496e1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784899268,
                "headline": "WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook"
              },
              {
                "id": 140998038,
                "url": "https://finnhub.io/api/news?id=a83730c15d5e88f5dbcdc33d8d84d1765555e0ab8e4ef4e8e83560f359cab296",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services Inc (WST) reports robust Q2 results with significant revenue and EPS growth, while raising full-year guidance amidst global expansion and strategic initiatives.",
                "category": "company",
                "datetime": 1784833298,
                "headline": "West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ..."
              },
              {
                "id": 140997834,
                "url": "https://finnhub.io/api/news?id=8b5562ccad08c40b36749e0aaa7782b3c5636767b2c337583a15476bb8c73561",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "WST tops Q2 earnings and revenue estimates, lifts its 2026 EPS outlook and sees shares surge as high-value products fuel strong growth.",
                "category": "company",
                "datetime": 1784830080,
                "headline": "WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth"
              },
              {
                "id": 140995005,
                "url": "https://finnhub.io/api/news?id=0b66667a8b4ad924345baf0b6d2e2487f9122989012774013f8e77b7b7f09f5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "While the top- and bottom-line numbers for West Pharmaceutical (WST) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
                "category": "company",
                "datetime": 1784813407,
                "headline": "West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 140993608,
                "url": "https://finnhub.io/api/news?id=d4e4688bf4dc2ee4d9238e59a8643a4c78970120d3d4d32033c44cc137c819d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784807901,
                "headline": "West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars"
              },
              {
                "id": 140994444,
                "url": "https://finnhub.io/api/news?id=21604ef6b6313fd7f7d8bd6b312ff93f99af637b3548e8dba4c60285b5569317",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (WST) Q2 2026 Earnings Call July 23, 2026 8:00 AM EDTCompany ParticipantsJohn Sweeney - Vice President of Investor...",
                "category": "company",
                "datetime": 1784806830,
                "headline": "West Pharmaceutical Services, Inc. (WST) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140993539,
                "url": "https://finnhub.io/api/news?id=d04390a2f5d1a2ac12c0498d11018ae4d58fdbbed2027ac4d48b1ecb9c06efa1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of +13.94% and +4.24%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784805304,
                "headline": "West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates"
              }
            ],
            "raw_source": [
              {
                "id": 141022425,
                "url": "https://finnhub.io/api/news?id=d1f78928e7480655f340713dfd950836c30c45378585800c56edff87a7b3ebc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (NYSE:WST) has entered new long-term exclusive and non-exclusive distributorship agreements with Daikyo Seiko. West Pharmaceutical will distribute Daikyo products outside Japan, while Daikyo will distribute more West products within Japan. The agreements are structured to run over the next decade, reinforcing the companies' cross-border partnership in drug packaging technologies. West Pharmaceutical Services comes into this new distribution arrangement with...",
                "category": "company",
                "datetime": 1785042740,
                "headline": "West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan"
              },
              {
                "id": 141012217,
                "url": "https://finnhub.io/api/news?id=911ae89653143291a794bac10769990b0fa08687ccc7ab39b3d6261569feb355",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HCA Healthcare's recent earnings report, which pointed to a 'negative payer mix shift.' This term refers to a change in the types of insurance patients have, in this case, an increase in uninsured individuals resulting from losses in health insurance exchange coverage. For HCA, this shift was significant, reducing pre-tax income by an estimated $400 million",
                "category": "company",
                "datetime": 1784933348,
                "headline": "Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know"
              },
              {
                "id": 141011008,
                "url": "https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "Get the weekly dividend update for Champions, Contenders & Challengers—read about the dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1784916411,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"
              },
              {
                "id": 141007082,
                "url": "https://finnhub.io/api/news?id=d659103d7d7b5ef979f73e9b619ecda56339bb5d1d3d2a3be050003d830e115a",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "WST",
                "summary": "Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1784910901,
                "headline": "Uncover the latest developments among S&P500 stocks in today's session."
              },
              {
                "id": 141007920,
                "url": "https://finnhub.io/api/news?id=87f8d85494584027365a3886769e86bfba2dbfdaab5bcc5ff6b64728ff179ba8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.",
                "category": "company",
                "datetime": 1784905740,
                "headline": "Here's Why You Should Add Cencora Stock to Your Portfolio Now"
              },
              {
                "id": 141007921,
                "url": "https://finnhub.io/api/news?id=81d9e34fdfd7a95dd140c3b55594eacb4f418e518b7d324ee8d3ea4ef365f1e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.",
                "category": "company",
                "datetime": 1784905500,
                "headline": "Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs"
              },
              {
                "id": 141006590,
                "url": "https://finnhub.io/api/news?id=b9d1dbac7b295758ca6240d77ce744fd68e68aaf1579f112a00365686f982e57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SOLV's innovation, cost savings and strong segment demand support growth, while raw material cost increases remain a key risk.",
                "category": "company",
                "datetime": 1784901600,
                "headline": "Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"
              },
              {
                "id": 141005494,
                "url": "https://finnhub.io/api/news?id=7dcccb74b106c019d246e857f0bdac3ee97e6369aa115bcd9f80be7816496e1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784899268,
                "headline": "WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook"
              },
              {
                "id": 141004552,
                "url": "https://finnhub.io/api/news?id=d23e098ae2c20882e87461faa9d40ca2c79f7c19fa20e35c11098ee1f230d26c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491276743/image_1491276743.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services beats Q2 earnings, raises FY guidance, and sees biologics-driven margin gains. Click to read this earnings analysis of WST stock.",
                "category": "company",
                "datetime": 1784880528,
                "headline": "West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift"
              },
              {
                "id": 141002334,
                "url": "https://finnhub.io/api/news?id=5e7f3ffcf3f03cc583f270f8c997b135e7a9dcd1cf65173f5c6354a4dd95a058",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (NYSE:WST) raised its full-year 2026 outlook after reporting second-quarter results that topped management’s expectations, supported by strong demand for high-value product components, biologics-related offerings and GLP-1 elastomers. Chief Executive Officer and Board C",
                "category": "company",
                "datetime": 1784862272,
                "headline": "West Pharmaceutical Services Q2 Earnings Call Highlights"
              },
              {
                "id": 141002552,
                "url": "https://finnhub.io/api/news?id=487079e6b61eefd5cdfca70b26da7a475a464155c3130cda555b6479781c524b",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "2026-07-24. The following slide deck was published by West Pharmaceutical Services, Inc.",
                "category": "company",
                "datetime": 1784854848,
                "headline": "West Pharmaceutical Services, Inc. 2026 Q2 - Results - Earnings Call Presentation"
              },
              {
                "id": 140999440,
                "url": "https://finnhub.io/api/news?id=a3c1300db9b580986e56e96dd609fb6a0f382e04b69ba61818e02e24abd0cd48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Moby summary of West Pharmaceutical Services, Inc.'s Q2 2026 earnings call",
                "category": "company",
                "datetime": 1784840928,
                "headline": "West Pharmaceutical Services, Inc. Q2 2026 Earnings Call Summary"
              },
              {
                "id": 140998038,
                "url": "https://finnhub.io/api/news?id=a83730c15d5e88f5dbcdc33d8d84d1765555e0ab8e4ef4e8e83560f359cab296",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services Inc (WST) reports robust Q2 results with significant revenue and EPS growth, while raising full-year guidance amidst global expansion and strategic initiatives.",
                "category": "company",
                "datetime": 1784833298,
                "headline": "West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ..."
              },
              {
                "id": 140997834,
                "url": "https://finnhub.io/api/news?id=8b5562ccad08c40b36749e0aaa7782b3c5636767b2c337583a15476bb8c73561",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "WST tops Q2 earnings and revenue estimates, lifts its 2026 EPS outlook and sees shares surge as high-value products fuel strong growth.",
                "category": "company",
                "datetime": 1784830080,
                "headline": "WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth"
              },
              {
                "id": 140997924,
                "url": "https://finnhub.io/api/news?id=c608774f8f6aaf6348c7b29c9bed00d94e9b347c5e5957dac96e10936ea0836d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.",
                "category": "company",
                "datetime": 1784827980,
                "headline": "Reasons to Add QuidelOrtho Stock in Your Portfolio for Now"
              },
              {
                "id": 140997925,
                "url": "https://finnhub.io/api/news?id=6bec2c14e0d73dedc4197d0c596b947fcead06678116ed6826e141f2ca4addf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SNN expands ASC Solutions with an integrated platform, analytics and partners to boost efficiency, growth and patient outcomes in outpatient care.",
                "category": "company",
                "datetime": 1784827620,
                "headline": "Smith+Nephew Expands ASC Platform to Support Value-Based Care"
              },
              {
                "id": 140997927,
                "url": "https://finnhub.io/api/news?id=68be10255c11549211d68a39b771f136b909b37f137f465234c6a8b5d1ac0697",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "OPKO Health's growth outlook rests on RAYALDEE, BioReference gains and partnerships, though losses and pipeline risks persist.",
                "category": "company",
                "datetime": 1784823660,
                "headline": "Here's Why You Should Retain OPK Stock in Your Portfolio for Now"
              },
              {
                "id": 140997797,
                "url": "https://finnhub.io/api/news?id=3cbb38d923198032baed48e5d05dc6047f885315cb8b30cb7e2d44f8a571886d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "CNMD's FDA-expanded AirSeal indication adds da Vinci 5 hex cannula compatibility, supporting broader use across Intuitive Surgical's robotic systems.",
                "category": "company",
                "datetime": 1784823060,
                "headline": "CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula"
              },
              {
                "id": 140995005,
                "url": "https://finnhub.io/api/news?id=0b66667a8b4ad924345baf0b6d2e2487f9122989012774013f8e77b7b7f09f5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "While the top- and bottom-line numbers for West Pharmaceutical (WST) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
                "category": "company",
                "datetime": 1784813407,
                "headline": "West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 140992858,
                "url": "https://finnhub.io/api/news?id=fc6e06457fb216266ed7ade2993afcedbedc6648f41f9685a003e7793ce61b00",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "WST",
                "summary": "Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.",
                "category": "company",
                "datetime": 1784810101,
                "headline": "These S&P500 stocks that are showing activity before the opening bell on Thursday."
              },
              {
                "id": 140993608,
                "url": "https://finnhub.io/api/news?id=d4e4688bf4dc2ee4d9238e59a8643a4c78970120d3d4d32033c44cc137c819d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784807901,
                "headline": "West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars"
              },
              {
                "id": 140994444,
                "url": "https://finnhub.io/api/news?id=21604ef6b6313fd7f7d8bd6b312ff93f99af637b3548e8dba4c60285b5569317",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (WST) Q2 2026 Earnings Call July 23, 2026 8:00 AM EDTCompany ParticipantsJohn Sweeney - Vice President of Investor...",
                "category": "company",
                "datetime": 1784806830,
                "headline": "West Pharmaceutical Services, Inc. (WST) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140994378,
                "url": "https://finnhub.io/api/news?id=e3a7ce5d82f7b847dbdf67897b280b68a1da3d34320d47d81285ae5103b86e72",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/23/Hand-arranging-Wood-Block-With-Icon-Heal.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WST",
                "summary": "West Pharmaceutical reported Q2 earnings and revenue beat, higher 2026 guidance, and continued strength in GLP-1 and HVP products.",
                "category": "company",
                "datetime": 1784806346,
                "headline": "West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum"
              },
              {
                "id": 140993539,
                "url": "https://finnhub.io/api/news?id=d04390a2f5d1a2ac12c0498d11018ae4d58fdbbed2027ac4d48b1ecb9c06efa1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of +13.94% and +4.24%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784805304,
                "headline": "West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 140992642,
                "url": "https://finnhub.io/api/news?id=812c6dd87d7a4f750682a61b3fab2d96f3371cda3b8f1d67c7eb0c77b20757ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) reported Q2 adjusted earnings Thursday of $2.37 per diluted share",
                "category": "company",
                "datetime": 1784804052,
                "headline": "West Pharmaceutical Services Q2 Adjusted Earnings, Net Sales Rise; 2026 Outlook Boosted"
              },
              {
                "id": 140992643,
                "url": "https://finnhub.io/api/news?id=de92933d5d07aadf49e6290ac92f05a6bbf8433032b3f320c44f84699e37b1ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.",
                "category": "company",
                "datetime": 1784800800,
                "headline": "West Reports Second-Quarter 2026 Results"
              },
              {
                "id": 140994379,
                "url": "https://finnhub.io/api/news?id=bfe6ab960e2f567243a916684c09e37fbb7d0afc5a37bf205759eadf4c762240",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WST",
                "summary": "West Pharmaceutical Servs (NYSE:WST) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below.\nBenzinga APIs provide real-time",
                "category": "company",
                "datetime": 1784798574,
                "headline": "Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call"
              },
              {
                "id": 140993809,
                "url": "https://finnhub.io/api/news?id=a47ad7f0bc8a271af3493561d9e532c43ff1705e233807236e6b2cf91a6dc883",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Companies Reporting Before The Bell\n• Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. \n• Dime Commercial (NYSE:DCOM) is expected to report",
                "category": "company",
                "datetime": 1784790711,
                "headline": "Earnings Scheduled For July 23, 2026"
              },
              {
                "id": 140994381,
                "url": "https://finnhub.io/api/news?id=a437a6a837d4598cff87e81087d1ad59fc9a505ce89c1dd31aca78b7350f3566",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "West Pharmaceutical Servs (NYSE:WST) raises FY2026 Adj EPS guidance from $8.40-$8.75 to $8.85-$9.05 vs $8.61 analyst estimate. Raises FY2026 sales outlook from $3.295 billion-$3.350 billion to $3.345 billion-$3.380",
                "category": "company",
                "datetime": 1784786949,
                "headline": "West Pharmaceutical Servs Raises FY2026 Adj EPS Guidance from $8.40-$8.75 to $8.85-$9.05 vs $8.61 Est; Raises FY2026 Sales Guidance from $3.295B-$3.350B to $3.345B-$3.380B vs $3.332B Est"
              },
              {
                "id": 140994382,
                "url": "https://finnhub.io/api/news?id=84ebed3f1bc7749097f271e9c1db21aa6a947e19e4b6393057c64785b8084b79",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $8.15-$8.50 to $8.85-$9.05 vs $8.41 analyst estimate..",
                "category": "company",
                "datetime": 1784786908,
                "headline": "West Pharmaceutical Servs Raises FY2026 GAAP EPS Guidance from $8.15-$8.50 to $8.85-$9.05 vs $8.41 Est"
              },
              {
                "id": 140994383,
                "url": "https://finnhub.io/api/news?id=94c45595e311a5a7d4074a554811853702f1b89c52ebe8f3c8aead621bee2935",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "West Pharmaceutical Servs (NYSE:WST) is looking for Q3 Adj EPS of $2.14-$2.24 vs $2.12 analyst estimate. sees sales of $820.000 million-$835.000 million vs $815.707 million analyst estimate.",
                "category": "company",
                "datetime": 1784786886,
                "headline": "West Pharmaceutical Servs Sees Q3 Adj EPS $2.14-$2.24 vs $2.12 Est; Sees Sales $820.000M-$835.000M vs $815.707M Est"
              },
              {
                "id": 140994384,
                "url": "https://finnhub.io/api/news?id=97986c99b8fe10a66f8e1579431e1d7674d878c22988c8103036bd4c88584816",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $2.08 by 13.94 percent. This is a 28.8 percent increase over earnings of $1.84 per share",
                "category": "company",
                "datetime": 1784786875,
                "headline": "West Pharmaceutical Servs Q2 Adj. EPS $2.37 Beats $2.08 Estimate, Sales $872.300M Beat $838.586M Estimate"
              },
              {
                "id": 140984968,
                "url": "https://finnhub.io/api/news?id=cc24f23f73b8e9a4fbf38becde0290a14b386c510f656569e512a54b753432ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results tomorrow before market open. Here’s what to expect.",
                "category": "company",
                "datetime": 1784737827,
                "headline": "West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For"
              },
              {
                "id": 140984919,
                "url": "https://finnhub.io/api/news?id=0441267e55f97ee798e15ff361d070bf1c8ed9dc01745bc7ba5ff30f934d5764",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology reach while targeting first-year EPS accretion.",
                "category": "company",
                "datetime": 1784737140,
                "headline": "Cardinal Health Expands Home Care Business With Two Acquisitions"
              },
              {
                "id": 140984920,
                "url": "https://finnhub.io/api/news?id=baf18e37cd128514c37b8ec0c38c1918eac8f805b29c5b540d025957786c2803",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.",
                "category": "company",
                "datetime": 1784732640,
                "headline": "Revvity to Launch Signals for Startups for Emerging Biotech Companies"
              },
              {
                "id": 140978882,
                "url": "https://finnhub.io/api/news?id=4757c19fd5969527f9d29b3ed3b233d35b094fd4f2882a21a324b468cd87c0a3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services stock has delivered a 64.7% return over the past year, yet the valuation checks and current pricing suggest it may no longer be an obvious bargain, with the Discounted Cash Flow (DCF) estimate pointing to a level that is roughly in line with where the shares trade today. After such a strong run, investors are weighing solid business developments against signals that the stock screens as expensive on several measures. Over the past 1 year, West Pharmaceutical...",
                "category": "company",
                "datetime": 1784686321,
                "headline": "West (WST) Stock Looks Pricey With Little Room Above Fair Value"
              },
              {
                "id": 140976533,
                "url": "https://finnhub.io/api/news?id=28aecd823d339afb471ca9026f1ca8d33d516ebbaeab490559e50e4ff1c45a6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "On July 21, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on August 5, 2026 to shareholders of record on July 29, 2026.",
                "category": "company",
                "datetime": 1784664000,
                "headline": "West Declares Quarterly Dividend"
              },
              {
                "id": 140973539,
                "url": "https://finnhub.io/api/news?id=fc59b28a72e9fb67c5de58ff9b6deef6c4e9908ebb0d5136f53ed8bdb8d7d728",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.",
                "category": "company",
                "datetime": 1784647920,
                "headline": "WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?"
              },
              {
                "id": 140973584,
                "url": "https://finnhub.io/api/news?id=16836b16b30266ddee8f327aa9d7b895752a5d1fd7496fd5c676215fdc6e4ee3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "OMCL heads into Q2 earnings with OmniSphere adoption, Connected Devices execution and recurring revenue growth ahead of July 30 results.",
                "category": "company",
                "datetime": 1784647860,
                "headline": "Omnicell to Report Q2 Earnings: OmniSphere in Focus"
              },
              {
                "id": 140971931,
                "url": "https://finnhub.io/api/news?id=893e8bb7b41a606d4a508201130b3480b11bfd298966a40792889fd1dd974627",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.",
                "category": "company",
                "datetime": 1784645280,
                "headline": "GEHC Launches MIM Anyware for Secure Remote Imaging Collaboration"
              },
              {
                "id": 140971621,
                "url": "https://finnhub.io/api/news?id=ecc1da10ef106529290939101533f8a9832eadb8bd45283aaf71baea5eb03546",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Wall Street closed lower on Monday, pulled down by healthcare and industrial stocks.",
                "category": "company",
                "datetime": 1784640360,
                "headline": "Stock Market News for July 21, 2026"
              },
              {
                "id": 140971999,
                "url": "https://finnhub.io/api/news?id=332614d04f934331b6fc86cdc065aae05629a2376bc4c6ae936078201a21fc45",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for West Pharmaceutical (WST), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.",
                "category": "company",
                "datetime": 1784639708,
                "headline": "Curious about West Pharmaceutical (WST) Q2 Performance? Explore Wall Street Estimates for Key Metrics"
              },
              {
                "id": 140962292,
                "url": "https://finnhub.io/api/news?id=d24c4fe2b5991843e4a8f72514f648c4b4214b09dcdb126e31ec51daa60783bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "MMSI vs. WST: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1784562005,
                "headline": "MMSI vs. WST: Which Stock Should Value Investors Buy Now?"
              },
              {
                "id": 140961057,
                "url": "https://finnhub.io/api/news?id=7b57cd626dbf5494bbcf5873b3e42358e0db50e5d14043ee30cf4dd6a6200c55",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ALGN reports Q2 results on July 29, with investors watching Clear Aligner growth as higher volumes and digital offerings shape quarterly performance.",
                "category": "company",
                "datetime": 1784558520,
                "headline": "Align Technology to Report Q2 Earnings: Clear Aligner Segment in Focus"
              },
              {
                "id": 140960847,
                "url": "https://finnhub.io/api/news?id=81a8003193de79a3dbfb4e8aa9044d29e2a2203770ac8a44b4e0a51c3b594d32",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother handling, one-handed use and surgical flexibility.",
                "category": "company",
                "datetime": 1784555640,
                "headline": "Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S."
              },
              {
                "id": 140936382,
                "url": "https://finnhub.io/api/news?id=c26d40ae96cad9381ff95484e035c0a112d0fbb5f231d9ab1d18d1ffceb82dfc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ISRG beats second-quarter earnings and revenue estimates, but shares fall after hours as procedure growth slows sequentially despite strong placements.",
                "category": "company",
                "datetime": 1784312400,
                "headline": "ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth"
              },
              {
                "id": 140934568,
                "url": "https://finnhub.io/api/news?id=fcdbb1523ac61c565eff444a9974ae081ef0444ebc3b4e416bbf2d2d7408ab7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.",
                "category": "company",
                "datetime": 1784302740,
                "headline": "Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio"
              },
              {
                "id": 140933172,
                "url": "https://finnhub.io/api/news?id=584d2c6e82fe4caccaa31dd276f5f01a46c4f00e0bf9305af59a41c44c6ee4d2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Inspire Medical's Inspire V rollout, broader approvals and clinical evidence support growth despite coding and reimbursement pressures.",
                "category": "company",
                "datetime": 1784299800,
                "headline": "Here's Why You Should Retain INSP Stock in Your Portfolio for Now"
              },
              {
                "id": 140933174,
                "url": "https://finnhub.io/api/news?id=38f4dc886f6f5743ddce9ccc18ddb6b253fbb91f98948f8770e782ace9535fed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.",
                "category": "company",
                "datetime": 1784298360,
                "headline": "GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health"
              },
              {
                "id": 140931558,
                "url": "https://finnhub.io/api/news?id=012004f741375de3d2cf9bdd808ee9d572e8649154baa617e16925a93870c1c0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The companies you own inside this consumer staples fund are collectively signaling stronger profits are on the way.",
                "category": "company",
                "datetime": 1784290043,
                "headline": "XLP's Future Earnings Outlook Is Tilting Up"
              },
              {
                "id": 140931624,
                "url": "https://finnhub.io/api/news?id=78f45187241bb602ff1b9e487a0b5f980141cdc475a6f4973e9bfcff22eb44a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The company is making its biggest strategic bet in a decade, and it has nothing to do with just hoping for higher metal prices.",
                "category": "company",
                "datetime": 1784289727,
                "headline": "What Could Fuel a Real Turnaround for Alcoa Stock?"
              },
              {
                "id": 140928295,
                "url": "https://finnhub.io/api/news?id=b510557269e15df9b6a36ac9e14308e0eb10c0f824b4bf69c02a92eb1d9150fa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "On July 14, 2026, Daikyo Seiko, Ltd. entered into two 10‑year Distributorship Agreements with West Pharmaceutical Services, making West the exclusive distributor of Daikyo products outside Japan and appointing Daikyo as a non‑exclusive distributor of West products in Japan, both with early termination options under specific conditions. This long-term cross-distribution structure deepens an existing partnership and could meaningfully reshape West’s global access to high-value injectable...",
                "category": "company",
                "datetime": 1784247427,
                "headline": "Did West’s Expanded Daikyo Distribution Deal Reshape West Pharmaceutical Services' (WST) GLP‑1 Component Investment Narrative?"
              },
              {
                "id": 140922882,
                "url": "https://finnhub.io/api/news?id=805b3102bcf62b35f0d64995f3019ba6d3f7b1dc92b5dbfe3d52bbf93f346ed4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) is back in focus after signing two long term distributorship agreements with Daikyo Seiko, expanding its role as exclusive distributor of Daikyo products outside Japan. See our latest analysis for West Pharmaceutical Services. Alongside the Daikyo agreements, West Pharmaceutical Services has been in focus ahead of its upcoming July 23 earnings release, with the stock showing a 30 day share price return of 8.32% and a 1 year total shareholder return of...",
                "category": "company",
                "datetime": 1784221960,
                "headline": "West Pharmaceutical Services (WST) Expands Daikyo Ties As Valuation Questions Grow"
              },
              {
                "id": 140922763,
                "url": "https://finnhub.io/api/news?id=dc4955263ecd30f9602dfc000f5bacd34f86464174631084d5e636d601f094f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.",
                "category": "company",
                "datetime": 1784216760,
                "headline": "Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?"
              },
              {
                "id": 140922823,
                "url": "https://finnhub.io/api/news?id=f0358eb2ef38cfac55cb710d83ab902a12899b63ff195ca18087e10e8ab46459",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.",
                "category": "company",
                "datetime": 1784216460,
                "headline": "Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery"
              },
              {
                "id": 140921221,
                "url": "https://finnhub.io/api/news?id=04cbc645f2a607054a9a97c3eafb4c1331d516813e8454f214b2e67053e84ce3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.",
                "category": "company",
                "datetime": 1784212500,
                "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now"
              },
              {
                "id": 140921222,
                "url": "https://finnhub.io/api/news?id=760e9c1c7d69df2359d6c692b681a4463b5c079b953e5eeac0dbaa9ba9811f44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GUTS' shares surge after Revita patients retain up to 84% of GLP-1-induced weight loss in a year, compared with 46% for sham patients.",
                "category": "company",
                "datetime": 1784211180,
                "headline": "Fractyl Health Stock Up on Encouraging One-Year Revita Study Results"
              },
              {
                "id": 140921357,
                "url": "https://finnhub.io/api/news?id=13b5758f1e30978957a4f5657f19a74c32f760c5204ba0b33028ee91b7e3ab8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784210413,
                "headline": "West Pharmaceutical Services (WST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"
              },
              {
                "id": 140911503,
                "url": "https://finnhub.io/api/news?id=908a23ff1f0b5b57234053413e27a0b4eb754eefe15823bc8c1f0f9ad0380c6f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical is riding on strong HVP demand, GLP-1 growth and Annex 1 adoption, but can these tailwinds outweigh capacity and concentration risks?",
                "category": "company",
                "datetime": 1784131560,
                "headline": "Reasons to Add West Pharmaceutical Stock to Your Portfolio Now"
              },
              {
                "id": 140909892,
                "url": "https://finnhub.io/api/news?id=4c0aee8ff9ef958a5fe5cc75e951d08aabf5abc02060b4cccaabe752b70a9a40",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.",
                "category": "company",
                "datetime": 1784125740,
                "headline": "AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands"
              },
              {
                "id": 140909893,
                "url": "https://finnhub.io/api/news?id=2bfd112b99c9ec3d18c09c29045b6009dd3dda4c7f8f478a9cb09ccd225bb69b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NPCE's RNS adoption, referral growth and AI innovation support expansion, while IGE timing and investments may pressure near-term profits.",
                "category": "company",
                "datetime": 1784125380,
                "headline": "Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now"
              },
              {
                "id": 140909894,
                "url": "https://finnhub.io/api/news?id=5f4a27d23414e1bdf4b2eb1d42435dc1bc39ac051ca7eab04eb773d42fc9a2b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.",
                "category": "company",
                "datetime": 1784120640,
                "headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now"
              },
              {
                "id": 140909895,
                "url": "https://finnhub.io/api/news?id=46345a98de08da41fa031ab46e797686326f9cd0769b7b49d99546bed55b740d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.",
                "category": "company",
                "datetime": 1784120460,
                "headline": "Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership"
              },
              {
                "id": 140915164,
                "url": "https://finnhub.io/api/news?id=59c13aea234913c35df157df67d54f0e532cc51b5f22b22118ce1cdfcd2640e9",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577026000093/wst-20260714.htmThe terms of the Agreements are substantially similar to the terms of the Amended and Restated Technology Exchange and",
                "category": "company",
                "datetime": 1784047107,
                "headline": "West Pharmaceutical Services Enters Into Multiple Amended Distribution And Crosslicensing Agreements With Daikyo Seiko"
              },
              {
                "id": 140898373,
                "url": "https://finnhub.io/api/news?id=7f5bdde751f9c35aa6159ecbf69ebd1e7c98ab35526de50e323e5694daee49eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DexCom's G7 15 Day wins Health Canada authorization, offering longer wear, high accuracy and smart features for adults with diabetes.",
                "category": "company",
                "datetime": 1784038800,
                "headline": "DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM"
              },
              {
                "id": 140898445,
                "url": "https://finnhub.io/api/news?id=8cce6b82d94a14e6f1c6129d038c9d068492f45c6095479b1ffc1aafdad7bbfa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DGX's Q2 results may reflect growth across physician, hospital and consumer channels as AI tools and advanced diagnostics gain traction.",
                "category": "company",
                "datetime": 1784037480,
                "headline": "Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus"
              },
              {
                "id": 140895339,
                "url": "https://finnhub.io/api/news?id=c1c02517fb2d6062636fc20fa28984d3617d173e198049742585adea5db0ca27",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.",
                "category": "company",
                "datetime": 1784014260,
                "headline": "Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry"
              },
              {
                "id": 140893163,
                "url": "https://finnhub.io/api/news?id=46ab8af4954f2c55b96c9dcc4fac01fcbea8eb6835d3ddf0b167fc79b10b3b56",
                "image": "",
                "source": "Fintel",
                "related": "WST",
                "summary": "",
                "category": "company",
                "datetime": 1783992975,
                "headline": "BNP Paribas Initiates Coverage of West Pharmaceutical Services (WST) with Outperform Recommendation"
              },
              {
                "id": 140891454,
                "url": "https://finnhub.io/api/news?id=c48b3adf14536d98a3f2c9bd599e37663da1836460c7202e661a41644c38992c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Over the past six months, West Pharmaceutical Services has been a great trade, beating the S&P 500 by 21.8%. Its stock price has climbed to $353.68, representing a healthy 30.1% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1783977039,
                "headline": "3 Reasons WST is Risky and 1 Stock to Buy Instead"
              },
              {
                "id": 140888587,
                "url": "https://finnhub.io/api/news?id=23fd34574599028cd6535e7a4f359605d176c869633009b46055b092da4d12f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.",
                "category": "company",
                "datetime": 1783960560,
                "headline": "5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds"
              },
              {
                "id": 140889748,
                "url": "https://finnhub.io/api/news?id=4a9d32405fef74bf948984183f8b05a5325641572534ed9b6fb88723687586a0",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "BNP Paribas  analyst Curtis Moiles   initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Outperform rating and announces Price Target of $447.",
                "category": "company",
                "datetime": 1783951796,
                "headline": "BNP Paribas Initiates Coverage On West Pharmaceutical Servs with Outperform Rating, Announces Price Target of $447"
              },
              {
                "id": 140887148,
                "url": "https://finnhub.io/api/news?id=f755ce910230db2fab4ba45921f5ab4a739d67532f62f69a5624d1105413a25f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.",
                "category": "company",
                "datetime": 1783950000,
                "headline": "Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology"
              },
              {
                "id": 140865321,
                "url": "https://finnhub.io/api/news?id=d8b895f918b69aa3f791b5813d215e5b0407ed0839da5edbebbafff8d5a6c577",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (NYSE:WST) has sold the rights and facilities related to its SmartDose 3.5 mL On Body Delivery System to AbbVie. The transaction shifts ownership of this specific large volume wearable injector platform while allowing West Pharmaceutical Services to focus on other drug delivery offerings. The deal reflects a change in how NYSE:WST is positioning its portfolio within the drug delivery and pharmaceutical packaging market. West Pharmaceutical Services operates in...",
                "category": "company",
                "datetime": 1783710711,
                "headline": "West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business"
              },
              {
                "id": 140864462,
                "url": "https://finnhub.io/api/news?id=5385dfbf612f8c20c2fd190bec7ce1355e17190a56528ddafaab67d9a11bf432",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "RMD's MatrixCare sale sharpens its focus on sleep, breathing and connected care while freeing resources for AI-powered digital health.",
                "category": "company",
                "datetime": 1783702260,
                "headline": "Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care"
              },
              {
                "id": 140863217,
                "url": "https://finnhub.io/api/news?id=831e7a1b5f03c8ec8a7acb247e1f14b0ba5af76cadbec1598f2bfde1ce4e12a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Natera's Signatera became the first personalized MRD test for solid tumors to earn EU IVDR certification, supporting broader expansion across Europe.",
                "category": "company",
                "datetime": 1783691940,
                "headline": "NTRA's Signatera Gains EU IVDR Certification for Multiple Cancers"
              },
              {
                "id": 140854881,
                "url": "https://finnhub.io/api/news?id=8a8a71a3c9b55bee523e560182a99d6baf883ba2c6c20a3a0ab132fcc4cbd0c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data from the MI-BET study.",
                "category": "company",
                "datetime": 1783618260,
                "headline": "GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics"
              },
              {
                "id": 140854892,
                "url": "https://finnhub.io/api/news?id=18d56e3451b55938acae77520d87891d3d93cfa24d640726485299e0559ad40a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.",
                "category": "company",
                "datetime": 1783617840,
                "headline": "Here's Why You Should Hold Avantor Stock in Your Portfolio for Now"
              },
              {
                "id": 140853625,
                "url": "https://finnhub.io/api/news?id=34789f5f113f6a52588b31ee2f767e7ebbad7b4fece69da69969249a3f369249",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Morgan Stanley  analyst Kallum Titchmarsh   maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $325 to $365.",
                "category": "company",
                "datetime": 1783604059,
                "headline": "Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $365"
              },
              {
                "id": 140852421,
                "url": "https://finnhub.io/api/news?id=bf98b7263ae913494a83afc2367aae3aabd4ac0b7bca40d2c16543bdd4e995f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "MMSI's portfolio, acquisitions, R&D strategy and WRAPSODY upside support growth, though tariffs, China pressure and OEM headwinds persist.",
                "category": "company",
                "datetime": 1783602300,
                "headline": "Here's Why You Should Add Merit Medical Stock to Your Portfolio Now"
              },
              {
                "id": 140852140,
                "url": "https://finnhub.io/api/news?id=9065ddccb771e28ec56c5988d49b27a98ddb5fc30b86b1aed6b7c9a0e1c17a27",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical completes the SmartDose 3.5mL sale to AbbVie, sharpening its focus on higher-growth on-body drug delivery technologies.",
                "category": "company",
                "datetime": 1783601760,
                "headline": "WST Completes SmartDose Sale to AbbVie to Focus on Core Growth"
              },
              {
                "id": 140844618,
                "url": "https://finnhub.io/api/news?id=0696ca8cb61577baf142127fac92706faf2f21f1a6d8e7562e6a4c017c0e1e06",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GKOS has surged nearly 45% since May-end as upbeat iDose TR commentary, strong sales and growth expectations lift investor confidence.",
                "category": "company",
                "datetime": 1783533840,
                "headline": "GKOS Stock Up More Than 45% Since May-End: What's Driving the Rally?"
              },
              {
                "id": 140841995,
                "url": "https://finnhub.io/api/news?id=2a9b52f2da4b5a22c4f058f2630f217896981d69db9faf8e3d076c2ef6f7a72e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "PODD expands Omnipod 5 to Spain, marking its 20th country launch and adding Omnipod Discover to strengthen digital diabetes care.",
                "category": "company",
                "datetime": 1783520460,
                "headline": "Insulet Broadens Omnipod 5 Presence With Commercial Launch in Spain"
              },
              {
                "id": 140839472,
                "url": "https://finnhub.io/api/news?id=dd881bcabc2bb19487918ffbc9709eff68916225493c5faeff1ce53c02d8bc5e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2220524615/image_2220524615.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential.",
                "category": "company",
                "datetime": 1783496560,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For July 2026"
              },
              {
                "id": 140833239,
                "url": "https://finnhub.io/api/news?id=6bf7eb024e3e983f00f4f777b09bd0b8e4fd1cbb880fa8d6b7c79993bda81bb6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "TMDX's PAD Aviation investment expands its OCS model into Europe, aiming to boost organ logistics, utilization and adoption.",
                "category": "company",
                "datetime": 1783442520,
                "headline": "TransMedics Completes PAD Aviation Investment to Expand in Europe"
              },
              {
                "id": 140833240,
                "url": "https://finnhub.io/api/news?id=6fd6462fceb8d3567d15298d34e8a29641d606525715a8fc5581223359872313",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressures weigh on instrument demand.",
                "category": "company",
                "datetime": 1783442340,
                "headline": "Here's Why You Should Add PacBio Stock to Your Portfolio Now"
              },
              {
                "id": 140833241,
                "url": "https://finnhub.io/api/news?id=206904f719267fab95937260f229994c94b9f7064efe652c6beef79acc409c38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.",
                "category": "company",
                "datetime": 1783440004,
                "headline": "West Pharmaceutical Services (WST) Is Up 4.24% in One Week: What You Should Know"
              },
              {
                "id": 140833242,
                "url": "https://finnhub.io/api/news?id=4af24d87beb067c911354fb12473a7911885f1717b580199c71692bce344cf3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "CDNA closes its Naveris buyout, adding NavDx and expanding its precision diagnostics reach into high-growth specialty oncology.",
                "category": "company",
                "datetime": 1783437780,
                "headline": "CareDx Completes Naveris Acquisition and Expands Oncology Reach"
              },
              {
                "id": 140833243,
                "url": "https://finnhub.io/api/news?id=f5e6cd39b4ab9e7d25a309f7c8839a0c5618157d9a1355ac7702c66e33f6a2ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AMN Healthcare's MSP momentum, labor disruption demand and AI-driven staffing tools support growth. But pricing pressure and industry shifts remain key risks.",
                "category": "company",
                "datetime": 1783437600,
                "headline": "Here's Why You Should Retain AMN Stock in Your Portfolio for Now"
              },
              {
                "id": 140828502,
                "url": "https://finnhub.io/api/news?id=882395097275b820088b1615e1c4dd68e90f69ab009ef89bc14c7b0628defdd1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2026 financial results before the market opens on Thursday, July 23, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.",
                "category": "company",
                "datetime": 1783418400,
                "headline": "West to Host Second-Quarter 2026 Conference Call"
              },
              {
                "id": 140823739,
                "url": "https://finnhub.io/api/news?id=de5c660ab808b83f81efd1c13698196a6f7779a16ee5d25f5a2c2b8c4dd30434",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DXCM's expanding CGM reach, G7 15 Day rollout and international momentum support growth, but can reimbursement and cost risks temper the outlook?",
                "category": "company",
                "datetime": 1783362840,
                "headline": "Here's Why You Should Retain DexCom Stock in Your Portfolio for Now"
              },
              {
                "id": 140822653,
                "url": "https://finnhub.io/api/news?id=d562896bfaf85581c24f56545a35f89f8e42d5f68617bb72268ab4af686e43c4",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Evercore ISI Group  analyst Daniel Markowitz   maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $390 to $410.",
                "category": "company",
                "datetime": 1783343185,
                "headline": "Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $410"
              },
              {
                "id": 140806023,
                "url": "https://finnhub.io/api/news?id=e1026b12a02518f74ae9ee2fe827ce4c6deafd5777cfa170ec57af501dd4eee4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services has delivered a strong 65.1% return over the past year, yet its valuation checks and current pricing suggest the stock is far from a clear bargain. Over the last 12 months, West Pharmaceutical Services shares are up 65.1%. This puts extra focus on whether recent gains already reflect investors' expectations. Anticipation of ongoing earnings growth and portfolio changes such as the sale of certain SmartDose manufacturing rights can support a higher valuation. Any...",
                "category": "company",
                "datetime": 1783152538,
                "headline": "West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings"
              },
              {
                "id": 140802850,
                "url": "https://finnhub.io/api/news?id=c5905c968be2d149392bf23b184b1bb711768e2b822b0fb6621edca56d2e06a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.",
                "category": "company",
                "datetime": 1783100460,
                "headline": "WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?"
              },
              {
                "id": 140800103,
                "url": "https://finnhub.io/api/news?id=dcc9de3c19106473c4f2342a577f213e9f9967657aeed167110a96c82335b286",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ECL's $4.75B CoolIT acquisition boosts its AI cooling portfolio and positions High-Tech as a major long-term growth engine.",
                "category": "company",
                "datetime": 1783087620,
                "headline": "Ecolab Closes CoolIT Acquisition, Strengthens AI Cooling Portfolio"
              },
              {
                "id": 140800149,
                "url": "https://finnhub.io/api/news?id=c6f4d206cde23a1054e469acd058468e6564ae1572d2e9b7561166e8743eff49",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BFLY launches Butterfly iQ+ and iQ3 in Brazil, expanding its handheld ultrasound reach into a major Latin American medical device market.",
                "category": "company",
                "datetime": 1783084560,
                "headline": "Butterfly Network Expands Handheld Ultrasound Reach in Brazil"
              },
              {
                "id": 140794141,
                "url": "https://finnhub.io/api/news?id=4bb98d880dbdc7140f8e6c1519fcef03e891672c4eea501ff1c888aa3fc46c25",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.",
                "category": "company",
                "datetime": 1783015860,
                "headline": "Here's Why You Should Retain McKesson Stock in Your Portfolio for Now"
              },
              {
                "id": 140793199,
                "url": "https://finnhub.io/api/news?id=51e6b94de8cbaa5872cc723672f79b0b8ff7d490df0b6a542f54dbb4b8da9241",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Butterfly Network's partner Aleph Neuro showcases non-invasive 3D brain imaging, highlighting the reach of its Ultrasound-on-Chip platform.",
                "category": "company",
                "datetime": 1783007580,
                "headline": "BFLY's Embedded Partner Unveils Breakthrough in Brain Imaging Tech"
              },
              {
                "id": 140791605,
                "url": "https://finnhub.io/api/news?id=fd38a14f1a1829541fca1dfca16f077cbcaa7f3b4dfd12a73f8a353bd04ebe5d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "RVTY expands Signals AI through Anthropic's MCP ecosystem, giving scientists secure Claude access to connected R&D data and scientific context.",
                "category": "company",
                "datetime": 1783000620,
                "headline": "Revvity Expands Signals AI With Anthropic Claude Integration"
              },
              {
                "id": 140794203,
                "url": "https://finnhub.io/api/news?id=f2d54940a2ad9dbd6fedb9d7e46f277d4c0553df710babdada329cd3c08a7402",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services will release its second-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.",
                "category": "company",
                "datetime": 1782995653,
                "headline": "What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report"
              },
              {
                "id": 140793586,
                "url": "https://finnhub.io/api/news?id=5719079199fad61059d7ab9721b9845d9594be7c506ae7e7b1d91d6bb65882d4",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Keybanc  analyst Paul Knight   maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target from $350 to $390.",
                "category": "company",
                "datetime": 1782982961,
                "headline": "Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $390"
              },
              {
                "id": 140784901,
                "url": "https://finnhub.io/api/news?id=f406dd28b17057902be7b05dab242944251c90ee3fac4448f587d5a89f5d12fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the company completed the sale and transfer of the manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities. The transaction closed as planned on July 1, 2026.",
                "category": "company",
                "datetime": 1782937800,
                "headline": "West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System"
              },
              {
                "id": 140783833,
                "url": "https://finnhub.io/api/news?id=576c27018db0999ab8b76ac7855c8c61131bd432dfe701c5d7053501ec6443d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NVCR secures European approval for Optune Pax, expanding access to its pancreatic cancer treatment after strong late-stage trial results.",
                "category": "company",
                "datetime": 1782925200,
                "headline": "NovoCure's Cancer Treatment Device Option Pax Gets European Approval"
              },
              {
                "id": 140782806,
                "url": "https://finnhub.io/api/news?id=4b46b013d5493a49e85752e83696e2df94aa4ead521f232e176a49136ad755f8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "MMSI vs. WST: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1782920403,
                "headline": "MMSI or WST: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 140780918,
                "url": "https://finnhub.io/api/news?id=3b0baa7fffab236dcd734cfa186452d7b002983187c1c1c0f73c405e72e3c28a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Natera's Aveta partnership brings Signatera into a global Phase 3 head and neck cancer trial to assess MRD and treatment response.",
                "category": "company",
                "datetime": 1782917760,
                "headline": "NTRA & Aveta Partner to Advance MRD-Guided Trial in Head & Neck Cancer"
              },
              {
                "id": 140780919,
                "url": "https://finnhub.io/api/news?id=621439d11636ccf6b1b941320580657de1764b4f53ab927405dece415eea4685",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AORT's FDA approval for AMDS removes a key hospital adoption hurdle and opens access to an estimated $150 million annual U.S. market.",
                "category": "company",
                "datetime": 1782915120,
                "headline": "Artivion Secures FDA Approval for AMDS Hybrid Prosthesis Device"
              },
              {
                "id": 140778916,
                "url": "https://finnhub.io/api/news?id=67954842b7236cee84749821d741f474c042ed1930efa085bf6d29f7b90cd49c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "In recent days, West Pharmaceutical Services reported revenue growth of 21%, reflecting increasing demand for its advanced drug containment and delivery solutions across healthcare markets. Analysts responded with a broadly positive outlook, highlighting how the company’s proprietary and contract-manufactured products may reinforce its role in supporting complex injectable therapies. Next, we’ll explore how this revenue surge and upbeat analyst sentiment might influence West Pharmaceutical...",
                "category": "company",
                "datetime": 1782900499,
                "headline": "West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable Demand - Has The Bull Case Changed?"
              },
              {
                "id": 140774638,
                "url": "https://finnhub.io/api/news?id=dc83ab0d3fde1184f1a677130808414e18be8381132f9c166c10ddb9ac190e61",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.",
                "category": "company",
                "datetime": 1782839700,
                "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now"
              },
              {
                "id": 140773031,
                "url": "https://finnhub.io/api/news?id=76d219ee13d1d746fa7ea6b4e360052ff48335f115712ebd040d824e41c815aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BTSG's specialty, infusion and provider services momentum support growth, but IRA pressures and integration risks may weigh on margins.",
                "category": "company",
                "datetime": 1782827580,
                "headline": "Here's Why You Should Add BrightSpring Stock to Your Portfolio Now"
              },
              {
                "id": 140773023,
                "url": "https://finnhub.io/api/news?id=ede32aa2516a6d0550caf8c6832bb94b765df08f33815bd01afc225e8303d633",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GE HealthCare's Allia upgrade pathways let providers modernize legacy imaging systems with AI-enabled workflows while reducing construction and disruption.",
                "category": "company",
                "datetime": 1782827340,
                "headline": "GEHC Launches Allia Upgrade Pathways for Interventional Suites"
              },
              {
                "id": 140764262,
                "url": "https://finnhub.io/api/news?id=8abc78b30ca2a87fd4b92e612fad2e20fb7adb4043868d2ce34acab38e539db0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "VEEV expands its AI push with Copli acquisition and Falcon MLR launch, aiming to speed life sciences content reviews and boost Commercial Cloud.",
                "category": "company",
                "datetime": 1782750360,
                "headline": "Veeva Acquires Copli & Launches Falcon MLR for Faster Content Reviews"
              },
              {
                "id": 140762774,
                "url": "https://finnhub.io/api/news?id=3d575f112a11a916aff42579a45ba497b46a0c94e48408924257bdf6b45601ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.",
                "category": "company",
                "datetime": 1782741180,
                "headline": "RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools"
              },
              {
                "id": 140744963,
                "url": "https://finnhub.io/api/news?id=d502d3e234636610a86a46fb082cae7d5af2639e1594755baf12d54b8bc8d7f9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215519735/image_2215519735.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.",
                "category": "company",
                "datetime": 1782541720,
                "headline": "Best Dividend Aristocrats: June 2026"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 112,
            "discarded_article_count": 87
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 13.5,
        "grade": "較差",
        "items": {
          "bbPoints": 1.8,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.6,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.6,
            "vcp_reason": "跌縮量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 811546.6666666666,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 760690,
              "avg_vol_20": 822105,
              "avg_vol_30": 811546.6666666666,
              "range_pct_10": 0.12279094689850856,
              "range_pct_20": 0.1319317144444937,
              "range_pct_30": 0.1951858563319361,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9373336509709855,
              "dist_to_20d_high": 0.14974090673575124,
              "down_shrink_days": 3,
              "breakout_level_20d": 386,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6290975647830156
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.4588969086259316,
              "turnoverUsdM": 495.122535086,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.WST",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 305.4958,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 6.9,
            "take_profit_price": 353.0043,
            "target_multiplier": 1.9,
            "technical_strength": 1.73,
            "take_profit_percent": 7.6
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.917793817251863,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 11.3521,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.46
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -326.78
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0043
    },
    "kdj": {
      "d": 43.59,
      "j": 2.43,
      "k": 29.87,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 50.11
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 7244900,
      "recentSlope": -446070,
      "previousSlope": 138870
    },
    "rsi": 29.78,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 360.8401,
      "position": "SAR喺價上",
      "distancePct": 9.95,
      "previousTrend": "下降"
    },
    "ma50": 334.7358,
    "macd": {
      "macd": 3.6674784969353595,
      "trend": "中性偏多",
      "signal": 7.164035179663757,
      "histogram": -3.4965566827283974
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 355.6325,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.85,
      "score": 6,
      "avgVolume": 816770,
      "currentVolume": 1508600
    },
    "derived": {
      "ma20": 356.236,
      "ma50": 334.7358,
      "prevClose": 355.48,
      "avgVolume10": 866940,
      "avgVolume20": 816770,
      "changePercent": -7.67,
      "avgVolumeForScore": 816770
    },
    "ma_cross": {
      "ma20": 356.236,
      "ma50": 334.7358,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 357.154,
      "prevMa50": 334.4132,
      "spreadPct": 6.42,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 341.3837,
      "upper": 371.0883,
      "position": "下半部"
    },
    "rsi_short": 14.39,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.85
    }
  }
}

{
  "close": 328.2,
  "volume": 1508600,
  "changePercent": -7.67
}